This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: drug-eluting stent

September 2021 Br J Cardiol 2021;28:166–8 doi:10.5837/bjc.2021.041

Post-stenting angiographically silent coronary dissection: OCT comes to the rescue

Roopali Khanna, Anindya Ghosh, Ankit Kumar Sahu, Pravin K Goel

Abstract

Introduction Coronary angiography and intravascular ultrasound (IVUS) have traditionally been used for diagnosis of stent edge dissection.1 Optical coherence tomography (OCT), with better resolution (12 to 18 µm) as compared with IVUS (150–250 µm), has higher chances of detecting stent edge dissection. Reported incidences of stent edge dissection range from 5% to 23% by IVUS,2 compared with 20% to 56% by OCT.3 Angiographic results are often deceiving and trials have confirmed that OCT changes the initial PCI strategy in a significant number of cases.4 Case summary A 58-year-old, non-diabetic, non-hypertensive, tobacco-chewing man present

| Full text
News from the American College of Cardiology Scientific Session 2011

June 2011 Br J Cardiol 2011;18:105–8

News from the American College of Cardiology Scientific Session 2011

BJCardio Staff

Abstract

PARTNER: transcatheter valves just as good as surgery for high risk aortic stenosis Transcatheter aortic valve implantation (TAVI) is just as effective at reducing mortality as surgery for severe aortic stenosis in elderly patients whose age and overall health posed high risks for conventional surgery, according to the results of the PARTNER (Placement of AoRTic TraNscathetER Valve trial). However, stroke rates were higher in the trancatheter group. The transcatheter approach involves delivering a bioprosthetic valve to its target location with a catheter using either transfemoral access or trans-apical access (through the ribs) if peripheral

| Full text

November 2009 Br J Cardiol 2009;16:269-71

Clopidogrel needed for more than one year after drug-eluting stent placement?

BJCardio editorial staff

Abstract

These results, from the TYCOON (Two-Year Clopidogrel Need) registry, were published online on September 28, 2009 in the American Journal of Cardiology. Current guidelines recommend at least 9-12 months of dual antiplatelet therapy (aspirin plus clopidogrel) following intervention with a drug-eluting stent to prevent thromboses, but authors of the TYCOON paper, wanted to investigate whether longer treatment would be better. The TYCOON database includes 897 consecutive patients who received a coronary stent in 2003 and 2004, about half of whom received a drug-eluting stent. Patients given a drug-eluting stent in 2003 were treated with clopidog

| Full text

September 2007 Br J Cardiol 2007;14:194-99

News from the 2007 Congress of the European Society of Cardiology

BJCardio editorial staff

Abstract

No content available

| Full text

September 2006 Br J Cardiol 2006;13:317-25

News from the 2006 Congress of the European Society of Cardiology and the XVth World Congress of Cardiology

BJCardio editorial team

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now